Zepbound vs Mounjaro: Same Medicine, Different Uses, Doses and Cost
Medically reviewed by Sabeen Munib M.D.Zepbound and Mounjaro are the same medicine, tirzepatide, made by Eli Lilly, in the same weekly doses. Zepbound is FDA approved for chronic weight management and obstructive sleep apnea, while Mounjaro is approved for type 2 diabetes. That difference in approved use mostly decides which brand your insurance covers and which one your doctor prescribes.
Are Zepbound and Mounjaro the same thing?
Yes and no. Zepbound and Mounjaro contain the same active ingredient, tirzepatide, made by Eli Lilly. The medicine, the dose strengths and the weekly injection schedule are the same. What differs is the FDA-approved use printed on each label, and that difference decides who can get which brand and how insurance treats it.
Tirzepatide acts on two gut hormone receptors, GIP and GLP-1. It slows how fast the stomach empties, lowers appetite and helps the body release insulin when blood sugar rises. That is why the same drug can treat type 2 diabetes under one name and support chronic weight management under another.
Who makes Mounjaro and Zepbound?
Eli Lilly makes both. Mounjaro came first, approved for type 2 diabetes in 2022. Zepbound followed in 2023 for weight management, and in 2024 it gained a second approval for obstructive sleep apnea.
Zepbound vs Mounjaro: what are the approved uses?
The approved uses are the main difference. Both labels pair the medicine with a reduced-calorie diet and more physical activity.
Zepbound is FDA approved for:
- Adults with obesity, or adults with overweight plus at least one weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes, to lose excess body weight and keep it off long term.
- Adults with obesity who have moderate to severe obstructive sleep apnea, to treat the sleep apnea.
Mounjaro is FDA approved for:
- Adults and children 10 years and older with type 2 diabetes, to improve blood sugar control alongside diet and exercise.
- Adults with type 2 diabetes who are at high risk of heart disease, to lower the risk of heart attack, stroke and death from heart disease.
Weight loss is a common effect of Mounjaro, but it is not an approved use on its own. If you do not have type 2 diabetes, Zepbound is the brand made for weight management. If you have type 2 diabetes, either brand may fit, and the choice often comes down to your blood sugar goals, weight goals and coverage.
Do Zepbound and Mounjaro have the same doses?
Yes. Both come in the same six weekly strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Both start the same way.
- 1.Start at 2.5 mg once a week for 4 weeks. This dose lets your body adjust and is not meant as a long-term dose.
- 2.Move to 5 mg once a week.
- 3.If needed, raise the dose by 2.5 mg, waiting at least 4 weeks at each step.
- 4.The maximum dose for adults is 15 mg once a week.
For weight management, the Zepbound label lists 5 mg, 10 mg or 15 mg as maintenance doses. For sleep apnea it lists 10 mg or 15 mg. For Mounjaro, the dose is raised only if more blood sugar control is needed, and children 10 and older stop at 10 mg. Slow steps lower the chance of nausea and other stomach side effects. If a dose is hard to tolerate, your doctor may hold you at a lower one.
How do you take tirzepatide?
- Inject once a week under the skin of the belly or thigh, or have someone else inject the back of your upper arm.
- Take it any time of day, with or without meals, on the same day each week.
- Missed dose: take it within 4 days. If more than 4 days have passed, skip it and take the next dose on your usual day.
- You can change your injection day as long as doses are at least 3 days apart.
Vials vs pens: is there a difference?
The medicine inside is the same. Both labels now list the same four ways the drug can be supplied:
- Single-dose pens with a hidden needle, used once and thrown away
- Single-dose vials, drawn up with a syringe
- Multi-dose vials holding 4 weekly doses
- A KwikPen holding 4 weekly doses for one person, never shared even with a new needle
Which form you receive depends on your prescription, your pharmacy and how you pay. Vials take a little more practice because you measure the dose yourself. If your form changes, ask for training on the new one and read its instructions, because the steps and dose volumes are different.
Zepbound vs Mounjaro cost: which is cheaper?
Neither is always cheaper. The list prices are similar, so what you actually pay depends on your insurance, your diagnosis and the form you use.
- Mounjaro is usually covered as a diabetes medicine for people with type 2 diabetes, often after the plan confirms the diagnosis.
- Zepbound coverage depends on whether your plan covers weight management medicines at all. Many plans require prior authorization, and some exclude these drugs.
- Medicare drug plans cannot cover medicines used only for weight loss, but they may cover Zepbound when it is prescribed for obstructive sleep apnea.
- Lilly runs a self-pay pharmacy, LillyDirect, that has sold Zepbound vials at a cash price, plus savings cards for some insured patients. Prices and rules change, so check the current offer before you fill.
- Pharmacy discount cards and warehouse pharmacies post their own cash prices, which also change often.
- HSA and FSA funds can usually be used for a prescription medicine.
For a full breakdown of Mounjaro prices, read our guide to Mounjaro cost without insurance
Zepbound vs Mounjaro side effects
The side effects are the same because the medicine is the same. Most involve the stomach, and they tend to be worst in the first weeks and after each dose increase.
Common side effects listed on the labels include:
- Nausea, diarrhea, vomiting and constipation
- Stomach pain, indigestion, burping and heartburn
- Decreased appetite
- Tiredness, hair loss and reactions where you inject
Small changes may ease them: eat smaller meals, stop when you feel full, avoid greasy foods and drink enough water.
Serious risks and the boxed warning
Both brands carry a boxed warning. Tirzepatide caused thyroid C-cell tumors in rats, and it is not known whether it causes these tumors, including medullary thyroid carcinoma, in people. Other serious risks on the prescribing information include:
- Pancreatitis, with severe stomach pain that may spread to the back
- Gallbladder problems, including gallstones
- Kidney injury from dehydration if vomiting or diarrhea is severe
- Serious allergic reactions
- Low blood sugar when taken with insulin or a sulfonylurea
- Worsening eye disease in people with a history of diabetic retinopathy
- A risk of breathing in stomach contents during anesthesia, so tell any surgeon you take it
Tirzepatide can also make birth control pills less reliable for 4 weeks after starting and after each dose increase. The label suggests a backup method or a non-pill option during those weeks.
Who should not take Zepbound or Mounjaro?
- Anyone with a personal or family history of medullary thyroid carcinoma
- Anyone with multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Anyone who has had a serious allergic reaction to tirzepatide
- Women who are pregnant. The Zepbound label says to stop when a pregnancy is recognized, since weight loss offers no benefit during pregnancy
- People with severe gastroparesis
- Anyone already taking another tirzepatide product or a GLP-1 medicine such as Ozempic or Wegovy
A history of pancreatitis, gallbladder disease or kidney disease needs a careful talk with your doctor first.
Can you switch from Mounjaro to Zepbound?
Yes, switching between the two brands is possible because the medicine is the same. The labels do not give a separate switching schedule, so your doctor decides the dose based on what you take now and how well you tolerate it.
- Never take Mounjaro and Zepbound together. That doubles the tirzepatide dose.
- A switch usually needs a new prescription and, for many plans, a new prior authorization.
- Common reasons to switch: a new type 2 diabetes diagnosis, a change in insurance, or a coverage decision tied to sleep apnea.
- If you missed several weeks, your doctor may restart at a lower dose to limit nausea.
Is Zepbound better than Mounjaro for weight loss?
No. At the same dose, Zepbound and Mounjaro are the same medicine, so neither works better for weight loss. The better choice is the one that matches your diagnosis, your coverage and the form you can use comfortably.
Tirzepatide is also often compared with semaglutide, the medicine in Ozempic and Wegovy. Those are a different drug that acts on GLP-1 only.
Read our comparison of semaglutide vs tirzepatide
How Dr. Munib approaches tirzepatide
The Pur Health prescribes brand-name GLP-1 medicines only: Wegovy, Ozempic, Zepbound and Mounjaro. Compounded tirzepatide is not offered. Dr. Munib prescribes both Zepbound and Mounjaro, depending on the reason for treatment.
A first visit may include your weight history, blood pressure, current medications, thyroid and family history, sleep symptoms, and labs such as A1C or blood sugar where they help. From there, she may discuss which brand fits your diagnosis and coverage, the starting dose, and how follow-up visits will track side effects, blood sugar and progress.
Learn about Zepbound at The Pur Health
When should you call a doctor?
- Severe stomach pain, especially pain that spreads to your back
- Vomiting or diarrhea you cannot keep up with, or signs of dehydration
- Pain in the upper right belly, fever, or yellow skin or eyes
- A lump in the neck, trouble swallowing or a hoarse voice that does not go away
- Swelling of the face, lips or throat, or trouble breathing
Book a visit in Irvine
If you are deciding between Zepbound and Mounjaro, or want to switch, a visit is the place to start. The Pur Health is in-network with most PPO plans. Cash visits are $190 for new patients and $150 for returning patients. We are at 114 Pacifica, Suite 280, Irvine, CA 92618, and you can call (949) 647-5234.